메뉴 건너뛰기




Volumn 9, Issue 1, 2011, Pages

Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CAPSID PROTEIN; MESSENGER RNA; PROTEIN L1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; GREEN FLUORESCENT PROTEIN; HPV L1 PROTEIN, HUMAN PAPILLOMAVIRUS; ONCOPROTEIN;

EID: 80355145645     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-190     Document Type: Article
Times cited : (14)

References (52)
  • 2
    • 0036132096 scopus 로고    scopus 로고
    • Estimates of the world-wide prevalence of cancer for 25 sites in the adult population
    • Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Canc 2002, 97:72-81.
    • (2002) Int J Canc , vol.97 , pp. 72-81
    • Pisani, P.1    Bray, F.2    Parkin, D.M.3
  • 3
    • 14944385553 scopus 로고    scopus 로고
    • Global cancer statistics, 2002
    • 10.3322/canjclin.55.2.74, 15761078
    • Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
    • (2005) CA Cancer J Clin , vol.55 , pp. 74-108
    • Parkin, D.M.1    Bray, F.2    Ferlay, J.3    Pisani, P.4
  • 4
    • 0023690889 scopus 로고
    • Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types
    • 10.1016/S0046-8177(88)80176-X, 2837431
    • Wilczynski SP, Bergen S, Walker J, Liao SY, Pearlman LF. Human papillomaviruses and cervical cancer: analysis of histopathologic features associated with different viral types. Hum Pathol 1988, 19:697-704. 10.1016/S0046-8177(88)80176-X, 2837431.
    • (1988) Hum Pathol , vol.19 , pp. 697-704
    • Wilczynski, S.P.1    Bergen, S.2    Walker, J.3    Liao, S.Y.4    Pearlman, L.F.5
  • 5
    • 0029041842 scopus 로고
    • Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group
    • 10.1093/jnci/87.11.796, 7791229
    • Bosch X, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman RJ, Shah KV. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995, 87:796-802. 10.1093/jnci/87.11.796, 7791229.
    • (1995) J Natl Cancer Inst , vol.87 , pp. 796-802
    • Bosch, X.1    Manos, M.M.2    Munoz, N.3    Sherman, M.4    Jansen, A.M.5    Peto, J.6    Schiffman, M.H.7    Moreno, V.8    Kurman, R.J.9    Shah, K.V.10
  • 6
    • 67349271268 scopus 로고    scopus 로고
    • Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer
    • 10.1016/j.yexmp.2009.01.009, 19454268
    • Palmer KE, Jenson AB, Kouokam JC, Lasnik AB, Ghim SJ. Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer. Exp Mol Pathol 2009, 86:224-233. 10.1016/j.yexmp.2009.01.009, 19454268.
    • (2009) Exp Mol Pathol , vol.86 , pp. 224-233
    • Palmer, K.E.1    Jenson, A.B.2    Kouokam, J.C.3    Lasnik, A.B.4    Ghim, S.J.5
  • 7
    • 33646058566 scopus 로고    scopus 로고
    • Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
    • 10.1016/S0140-6736(06)68439-0, 16631880, HPV Vaccine Study group
    • Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins D, Schuind A, Costa Clemens SA, Dubin G, . HPV Vaccine Study group Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006, 367:1247-1255. 10.1016/S0140-6736(06)68439-0, 16631880, HPV Vaccine Study group.
    • (2006) Lancet , vol.367 , pp. 1247-1255
    • Harper, D.M.1    Franco, E.L.2    Wheeler, C.M.3    Moscicki, A.B.4    Romanowski, B.5    Roteli-Martins, C.M.6    Jenkins, D.7    Schuind, A.8    Costa Clemens, S.A.9    Dubin, G.10
  • 8
    • 38449112974 scopus 로고    scopus 로고
    • Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection
    • 10.1086/522869, 18008218, FUTURE II Study Group
    • FUTURE II Study Group Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with virological evidence of HPV infection. J Infect Dis 2007, 196:1431-1432. 10.1086/522869, 18008218, FUTURE II Study Group.
    • (2007) J Infect Dis , vol.196 , pp. 1431-1432
  • 10
    • 33847391616 scopus 로고    scopus 로고
    • Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial
    • 10.1097/01.inf.0000253970.29190.5a, 17484215
    • Reisinger KS, Block S, Lazcano-Ponce E, Samakoses R, Esser MT, Erick J, Puchalski D, Giacoletti KE, Sings HL, Lukac S, Alvarez FB, Barr E. Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial. Pediatr Infect Dis J 2007, 26:201-209. 10.1097/01.inf.0000253970.29190.5a, 17484215.
    • (2007) Pediatr Infect Dis J , vol.26 , pp. 201-209
    • Reisinger, K.S.1    Block, S.2    Lazcano-Ponce, E.3    Samakoses, R.4    Esser, M.T.5    Erick, J.6    Puchalski, D.7    Giacoletti, K.E.8    Sings, H.L.9    Lukac, S.10    Alvarez, F.B.11    Barr, E.12
  • 12
    • 43949083734 scopus 로고    scopus 로고
    • A direct comparison of human PV type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response
    • 10.1128/JVI.02482-07, 2395182, 18385253
    • Thönes N, Herreiner A, Schadlich L, Piuko K, Müller M. A direct comparison of human PV type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response. J Virol 2008, 82:5472-5485. 10.1128/JVI.02482-07, 2395182, 18385253.
    • (2008) J Virol , vol.82 , pp. 5472-5485
    • Thönes, N.1    Herreiner, A.2    Schadlich, L.3    Piuko, K.4    Müller, M.5
  • 13
    • 74249097772 scopus 로고    scopus 로고
    • Prospects for new human papillomavirus vaccines
    • 10.1097/QCO.0b013e328334c0e1, 19926987
    • Stanley M. Prospects for new human papillomavirus vaccines. Curr Opin Infect Dis 2010, 23:70-75. 10.1097/QCO.0b013e328334c0e1, 19926987.
    • (2010) Curr Opin Infect Dis , vol.23 , pp. 70-75
    • Stanley, M.1
  • 14
    • 49749105995 scopus 로고    scopus 로고
    • An update of prophylactic human PV L1 virus-like particle vaccine clinical trial results
    • Schiller JT, Castellsague X, Villa LL, Hildesheim A. An update of prophylactic human PV L1 virus-like particle vaccine clinical trial results. Vaccine 2011, 26:K53-K61.
    • (2011) Vaccine , vol.26
    • Schiller, J.T.1    Castellsague, X.2    Villa, L.L.3    Hildesheim, A.4
  • 15
    • 79955476377 scopus 로고    scopus 로고
    • Papillomavirus virus like particle-based therapeutic vaccine against human papillomavirus infection related diseases: Immunological problems and future directions
    • 10.1016/j.cellimm.2011.03.003, 21477796
    • Chen J, Ni G, Liu XS. Papillomavirus virus like particle-based therapeutic vaccine against human papillomavirus infection related diseases: Immunological problems and future directions. Cell Immunol 2011, 269:5-9. 10.1016/j.cellimm.2011.03.003, 21477796.
    • (2011) Cell Immunol , vol.269 , pp. 5-9
    • Chen, J.1    Ni, G.2    Liu, X.S.3
  • 16
    • 67449094695 scopus 로고    scopus 로고
    • Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines
    • 10.1128/JVI.02443-08, 2698533, 19386711
    • Bellone S, El-Sahwi K, Cocco E, Casagrande F, Cargnelutti M, Palmieri M, Bignotti E, Romani C, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD. Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients: implications for L1 dendritic cell-based therapeutic vaccines. J Virol 2009, 83:6779-6789. 10.1128/JVI.02443-08, 2698533, 19386711.
    • (2009) J Virol , vol.83 , pp. 6779-6789
    • Bellone, S.1    El-Sahwi, K.2    Cocco, E.3    Casagrande, F.4    Cargnelutti, M.5    Palmieri, M.6    Bignotti, E.7    Romani, C.8    Silasi, D.A.9    Azodi, M.10    Schwartz, P.E.11    Rutherford, T.J.12    Pecorelli, S.13    Santin, A.D.14
  • 18
    • 0035873329 scopus 로고    scopus 로고
    • Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro
    • Rudolf MP, Fausch SC, Da Silva DM, Kast WM. Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro. J Immunol 2001, 166:5917-5924.
    • (2001) J Immunol , vol.166 , pp. 5917-5924
    • Rudolf, M.P.1    Fausch, S.C.2    Da Silva, D.M.3    Kast, W.M.4
  • 19
    • 0032843743 scopus 로고    scopus 로고
    • Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA
    • 10.1016/S0264-410X(99)00257-1, 10519927
    • Wyatt LS, Whitehead SS, Venanzi KA, Murphy BR, Moss B. Priming and boosting immunity to respiratory syncytial virus by recombinant replication-defective vaccinia virus MVA. Vaccine 1999, 18:392-397. 10.1016/S0264-410X(99)00257-1, 10519927.
    • (1999) Vaccine , vol.18 , pp. 392-397
    • Wyatt, L.S.1    Whitehead, S.S.2    Venanzi, K.A.3    Murphy, B.R.4    Moss, B.5
  • 20
    • 0026009499 scopus 로고
    • Complication of intramuscular/subcutaneous immune therapy in severely immune-compromised individuals
    • Picard O, Lebas J, Imbert JC, Bigel P, Zagury D. Complication of intramuscular/subcutaneous immune therapy in severely immune-compromised individuals. J Acquir Immune Defic Syndr 1991, 4:641-643.
    • (1991) J Acquir Immune Defic Syndr , vol.4 , pp. 641-643
    • Picard, O.1    Lebas, J.2    Imbert, J.C.3    Bigel, P.4    Zagury, D.5
  • 21
    • 46049083590 scopus 로고    scopus 로고
    • Viral vectors for production of recombinant proteins in plants
    • 10.1002/jcp.21423, 18330886
    • Lico C, Chen Q, Santi L. Viral vectors for production of recombinant proteins in plants. J Cell Physiol 2008, 216:366-377. 10.1002/jcp.21423, 18330886.
    • (2008) J Cell Physiol , vol.216 , pp. 366-377
    • Lico, C.1    Chen, Q.2    Santi, L.3
  • 22
    • 34248172560 scopus 로고    scopus 로고
    • Optimization of human papillomavirus type 16(HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization
    • 10.1099/vir.0.82718-0, 17412974
    • Maclean J, Koekemoer M, Olivier AJ, Stewart D, Hitzeroth II, Rademacher T, Fischer R, Williamson AL, Rybicki EP. Optimization of human papillomavirus type 16(HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. J Gen Virol 2007, 88:1460-1469. 10.1099/vir.0.82718-0, 17412974.
    • (2007) J Gen Virol , vol.88 , pp. 1460-1469
    • Maclean, J.1    Koekemoer, M.2    Olivier, A.J.3    Stewart, D.4    Hitzeroth, I.I.5    Rademacher, T.6    Fischer, R.7    Williamson, A.L.8    Rybicki, E.P.9
  • 23
    • 60349104850 scopus 로고    scopus 로고
    • An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice
    • 10.1186/1743-422X-6-2, 2639544, 19126233
    • Paz De la Rosa G, Monroy-García A, Mora-García Mde L, Peña CG, Hernández-Montes J, Weiss-Steider B, Gómez-Lim MA. An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice. Virol J 2009, 6:2. 10.1186/1743-422X-6-2, 2639544, 19126233.
    • (2009) Virol J , vol.6 , pp. 2
    • Paz De la Rosa, G.1    Monroy-García, A.2    Mora-García Mde, L.3    Peña, C.G.4    Hernández-Montes, J.5    Weiss-Steider, B.6    Gómez-Lim, M.A.7
  • 24
    • 0024264598 scopus 로고
    • Fowlpox virus as a vector in non-avian species
    • 10.1016/0264-410X(88)90091-6, 2854335
    • Taylor J, Paoletti E. Fowlpox virus as a vector in non-avian species. Vaccine 1988, 6:466-468. 10.1016/0264-410X(88)90091-6, 2854335.
    • (1988) Vaccine , vol.6 , pp. 466-468
    • Taylor, J.1    Paoletti, E.2
  • 25
    • 0026604536 scopus 로고
    • Potential use of nonreplicating vectors as recombinant vaccines
    • 10.1016/0264-410X(92)90411-C, 1311489
    • Baxby D, Paoletti E. Potential use of nonreplicating vectors as recombinant vaccines. Vaccine 1992, 10:8-9. 10.1016/0264-410X(92)90411-C, 1311489.
    • (1992) Vaccine , vol.10 , pp. 8-9
    • Baxby, D.1    Paoletti, E.2
  • 26
    • 14744274585 scopus 로고    scopus 로고
    • Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry
    • 10.1586/14760584.4.1.63, 15757474
    • Skinner MA, Laidlaw SM, Eldaghayes I, Kaiser P, Cottingham MG. Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry. Expert Rev Vaccines 2005, 4:63-76. 10.1586/14760584.4.1.63, 15757474.
    • (2005) Expert Rev Vaccines , vol.4 , pp. 63-76
    • Skinner, M.A.1    Laidlaw, S.M.2    Eldaghayes, I.3    Kaiser, P.4    Cottingham, M.G.5
  • 27
    • 4344684061 scopus 로고    scopus 로고
    • Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors
    • 10.1586/14760584.3.4.S75, 15285707
    • Franchini G, Gurunathan S, Baglyos L, Plotkin S, Tartaglia J. Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors. Expert Rev Vaccines 2004, 3:S75-S88. 10.1586/14760584.3.4.S75, 15285707.
    • (2004) Expert Rev Vaccines , vol.3
    • Franchini, G.1    Gurunathan, S.2    Baglyos, L.3    Plotkin, S.4    Tartaglia, J.5
  • 28
    • 0030663697 scopus 로고    scopus 로고
    • Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors
    • 10.1093/jnci/89.21.1595, 9362157
    • Irvine KR, Chamberlain RS, Shulman EP, Rosenberg SA, Restifo NP. Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors. J Natl Cancer Inst 1997, 89:1595-1601. 10.1093/jnci/89.21.1595, 9362157.
    • (1997) J Natl Cancer Inst , vol.89 , pp. 1595-1601
    • Irvine, K.R.1    Chamberlain, R.S.2    Shulman, E.P.3    Rosenberg, S.A.4    Restifo, N.P.5
  • 29
    • 0024267575 scopus 로고
    • Recombinant fowlpox virus inducing protective immunity in nonavian species
    • 10.1016/0264-410X(88)90100-4, 2854338
    • Taylor J, Weinberg R, Languet B, Desmettre P, Paoletti E. Recombinant fowlpox virus inducing protective immunity in nonavian species. Vaccine 1988, 6:497-503. 10.1016/0264-410X(88)90100-4, 2854338.
    • (1988) Vaccine , vol.6 , pp. 497-503
    • Taylor, J.1    Weinberg, R.2    Languet, B.3    Desmettre, P.4    Paoletti, E.5
  • 30
    • 34248175173 scopus 로고    scopus 로고
    • Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins
    • 10.1186/1750-9378-1-6, 1660559, 17150135
    • Di Bonito P, Grasso F, Mochi S, Accardi L, Donà MG, Branca M, Costa S, Mariani L, Agarossi A, Ciotti M, Syrjänen K, Giorgi C. Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins. Infect Agent Cancer 2006, 1:6-14. 10.1186/1750-9378-1-6, 1660559, 17150135.
    • (2006) Infect Agent Cancer , vol.1 , pp. 6-14
    • Di Bonito, P.1    Grasso, F.2    Mochi, S.3    Accardi, L.4    Donà, M.G.5    Branca, M.6    Costa, S.7    Mariani, L.8    Agarossi, A.9    Ciotti, M.10    Syrjänen, K.11    Giorgi, C.12
  • 31
    • 0034850163 scopus 로고    scopus 로고
    • Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes
    • 10.1128/JVI.75.19.9201-9209.2001, 114488, 11533183
    • Leder C, Kleinschmidt JA, Wiethe C, Müller M. Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol 2001, 75:9201-9209. 10.1128/JVI.75.19.9201-9209.2001, 114488, 11533183.
    • (2001) J Virol , vol.75 , pp. 9201-9209
    • Leder, C.1    Kleinschmidt, J.A.2    Wiethe, C.3    Müller, M.4
  • 32
    • 0023002660 scopus 로고
    • Conserved TAAATG Sequence at the Transcriptional and Translational Initiation Sites of Vaccinia Virus Late Genes Deduced by Structural and Functional Analysis of the Hindlll H Genome Fragment
    • 288911, 3021979
    • Rosel JL, Earl PL, Weir J, Moss B. Conserved TAAATG Sequence at the Transcriptional and Translational Initiation Sites of Vaccinia Virus Late Genes Deduced by Structural and Functional Analysis of the Hindlll H Genome Fragment. J Virol 1986, 60:436-449. 288911, 3021979.
    • (1986) J Virol , vol.60 , pp. 436-449
    • Rosel, J.L.1    Earl, P.L.2    Weir, J.3    Moss, B.4
  • 33
    • 0037449089 scopus 로고    scopus 로고
    • Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmid and virus-like particles in prime-boost vaccination protocols against SHIV
    • 10.1016/S0264-410X(02)00773-9, 12706695
    • Radaelli A, Zanotto C, Perletti G, Elli V, Vicenzi E, Poli G, De Giuli Morghen C. Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmid and virus-like particles in prime-boost vaccination protocols against SHIV. Vaccine 2003, 21:2052-2064. 10.1016/S0264-410X(02)00773-9, 12706695.
    • (2003) Vaccine , vol.21 , pp. 2052-2064
    • Radaelli, A.1    Zanotto, C.2    Perletti, G.3    Elli, V.4    Vicenzi, E.5    Poli, G.6    De Giuli Morghen, C.7
  • 34
    • 0030862430 scopus 로고    scopus 로고
    • Compact, synthetic, vaccinia virus early/late promoter for protein expression
    • Chakrabarti S, Sisler JR, Moss B. Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 1997, 23:1094-1097.
    • (1997) Biotechniques , vol.23 , pp. 1094-1097
    • Chakrabarti, S.1    Sisler, J.R.2    Moss, B.3
  • 35
    • 0027968853 scopus 로고
    • Expression of HIV-1 envelope gene by recombinant avipoxvirus
    • 10.1016/0264-410X(94)90180-5, 7998420
    • Radaelli A, De Giuli Morghen C. Expression of HIV-1 envelope gene by recombinant avipoxvirus. Vaccine 1994, 12:1101-1109. 10.1016/0264-410X(94)90180-5, 7998420.
    • (1994) Vaccine , vol.12 , pp. 1101-1109
    • Radaelli, A.1    De Giuli Morghen, C.2
  • 36
    • 0028241837 scopus 로고
    • Studies of fowlpox virus recombination in the generation of recombinant vaccines
    • 10.1016/0168-1702(94)90078-7, 8079511
    • Parks RJ, Krell PJ, Derbyshire JB, Nagy E. Studies of fowlpox virus recombination in the generation of recombinant vaccines. Virus Res 1994, 32:283-297. 10.1016/0168-1702(94)90078-7, 8079511.
    • (1994) Virus Res , vol.32 , pp. 283-297
    • Parks, R.J.1    Krell, P.J.2    Derbyshire, J.B.3    Nagy, E.4
  • 37
    • 0345308734 scopus 로고    scopus 로고
    • U.S. National Institutes of Health, Bethesda, Maryland, USA
    • Rasband WS. U.S. National Institutes of Health, Bethesda, Maryland, USA. 2009, , http://rsb.info.nih.gov/ij/
    • (2009)
    • Rasband, W.S.1
  • 38
    • 0030577120 scopus 로고    scopus 로고
    • Papillomavirus infections-a major cause of human cancers
    • zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996, 1288:F55-F78.
    • (1996) Biochim Biophys Acta , vol.1288
    • zur Hausen, H.1
  • 39
    • 0032840918 scopus 로고    scopus 로고
    • Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
    • 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482
    • Walboomers JM, Jacobs MV, Manos MM, Bosch X, Kummer JA, Shah KV, Snjders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482.
    • (1999) J Pathol , vol.189 , pp. 12-19
    • Walboomers, J.M.1    Jacobs, M.V.2    Manos, M.M.3    Bosch, X.4    Kummer, J.A.5    Shah, K.V.6    Snjders, P.J.7    Peto, J.8    Meijer, C.J.9    Munoz, N.10
  • 40
    • 0026793961 scopus 로고
    • HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions
    • 10.1016/0042-6822(92)91251-O, 1382345
    • Ghim SJ, Jenson AB, Schlegel R. HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions. Virology 1992, 190:548-552. 10.1016/0042-6822(92)91251-O, 1382345.
    • (1992) Virology , vol.190 , pp. 548-552
    • Ghim, S.J.1    Jenson, A.B.2    Schlegel, R.3
  • 41
    • 0027050013 scopus 로고
    • Papillomavirus Li major capsid protein self-assembles into virus-like particles that are highly immunogenic
    • 10.1073/pnas.89.24.12180, 50722, 1334560
    • Kirnbauer R, Booy N, Chengt DR, Lowy DR, Schiller JT. Papillomavirus Li major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci USA 1992, 89:12180-12184. 10.1073/pnas.89.24.12180, 50722, 1334560.
    • (1992) Proc Natl Acad Sci USA , vol.89 , pp. 12180-12184
    • Kirnbauer, R.1    Booy, N.2    Chengt, D.R.3    Lowy, D.R.4    Schiller, J.T.5
  • 42
    • 0027516212 scopus 로고
    • Expression of human PV type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles
    • 240261, 8383219
    • Rose RC, Bonnez W, Reichman RC, Garcea RL. Expression of human PV type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol 1993, 67:1936-1944. 240261, 8383219.
    • (1993) J Virol , vol.67 , pp. 1936-1944
    • Rose, R.C.1    Bonnez, W.2    Reichman, R.C.3    Garcea, R.L.4
  • 43
    • 0028845930 scopus 로고
    • Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation
    • 10.1016/0264-410X(95)00103-8, 8578834
    • Jansen KU, Rosolowsky M, Schultz LD, Markus HZ, Cook JC, Donnelly JJ, Martinez D, Ellis RW, Shaw AR. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine 1995, 13:1509-1514. 10.1016/0264-410X(95)00103-8, 8578834.
    • (1995) Vaccine , vol.13 , pp. 1509-1514
    • Jansen, K.U.1    Rosolowsky, M.2    Schultz, L.D.3    Markus, H.Z.4    Cook, J.C.5    Donnelly, J.J.6    Martinez, D.7    Ellis, R.W.8    Shaw, A.R.9
  • 44
    • 72649094063 scopus 로고    scopus 로고
    • Production of immunogenic human papillomavirus-16 major capsid protein derived virus like particles
    • Patel MC, Patkar KK, Basu A, Mohandas KM, Mukhopadhyaya R. Production of immunogenic human papillomavirus-16 major capsid protein derived virus like particles. Indian J Med Res 2009, 130:213-218.
    • (2009) Indian J Med Res , vol.130 , pp. 213-218
    • Patel, M.C.1    Patkar, K.K.2    Basu, A.3    Mohandas, K.M.4    Mukhopadhyaya, R.5
  • 45
    • 0029063294 scopus 로고
    • Sequence determination of human PV type 6a and assembly of virus-like particles in Saccharomyces cerevisiae
    • 10.1006/viro.1995.1283, 7778283
    • Hofmann KJ, Cook JC, Joyce JG, Brown DR, Schultz LD, George HA, Rosolowsky M, Fife KH, Jansen KU. Sequence determination of human PV type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology 1995, 209:506-518. 10.1006/viro.1995.1283, 7778283.
    • (1995) Virology , vol.209 , pp. 506-518
    • Hofmann, K.J.1    Cook, J.C.2    Joyce, J.G.3    Brown, D.R.4    Schultz, L.D.5    George, H.A.6    Rosolowsky, M.7    Fife, K.H.8    Jansen, K.U.9
  • 46
    • 33747877038 scopus 로고    scopus 로고
    • Chapter 13: Current findings from prophylactic HPV vaccine trials
    • Koutsky LA, Harper DM. Chapter 13: Current findings from prophylactic HPV vaccine trials. Vaccine 2006, 24:S114-S121.
    • (2006) Vaccine , vol.24
    • Koutsky, L.A.1    Harper, D.M.2
  • 47
    • 50849122065 scopus 로고    scopus 로고
    • Immunobiology of human PV infection and vaccination-implications for second generation vaccines
    • Stanley M, Gissmann L, Nardelli-Haefliger D. Immunobiology of human PV infection and vaccination-implications for second generation vaccines. Vaccine 2008, 26:K62-K67.
    • (2008) Vaccine , vol.26
    • Stanley, M.1    Gissmann, L.2    Nardelli-Haefliger, D.3
  • 48
    • 77956930202 scopus 로고    scopus 로고
    • Canarypox and fowlpox viruses as recombinant vaccine vectors: a biological and immunological comparison
    • 10.1016/j.antiviral.2010.07.005, 20643163
    • Zanotto C, Pozzi E, Pacchioni S, Volonté L, De Giuli Morghen C, Radaelli A. Canarypox and fowlpox viruses as recombinant vaccine vectors: a biological and immunological comparison. Antiviral Res 2010, 88:53-63. 10.1016/j.antiviral.2010.07.005, 20643163.
    • (2010) Antiviral Res , vol.88 , pp. 53-63
    • Zanotto, C.1    Pozzi, E.2    Pacchioni, S.3    Volonté, L.4    De Giuli Morghen, C.5    Radaelli, A.6
  • 50
    • 0033696899 scopus 로고    scopus 로고
    • Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16
    • 10.1016/S1097-2765(00)80449-9, 10882140
    • Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell 2000, 5:557-567. 10.1016/S1097-2765(00)80449-9, 10882140.
    • (2000) Mol Cell , vol.5 , pp. 557-567
    • Chen, X.S.1    Garcea, R.L.2    Goldberg, I.3    Casini, G.4    Harrison, S.C.5
  • 51
    • 36049000191 scopus 로고    scopus 로고
    • Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes
    • 10.1016/j.virol.2007.08.004, 17822733
    • Thönes N, Müller M. Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes. Virology 2007, 369:375-388. 10.1016/j.virol.2007.08.004, 17822733.
    • (2007) Virology , vol.369 , pp. 375-388
    • Thönes, N.1    Müller, M.2
  • 52
    • 62249214234 scopus 로고    scopus 로고
    • Generation of recombinant vaccinia viruses via green fluorescent protein selection
    • 10.1089/dna.2008.0792, 2925039, 19182996
    • Popov S, Mirshahidi S, Essono S, Song R, Wang X, Ruprecht RM. Generation of recombinant vaccinia viruses via green fluorescent protein selection. DNA Cell Biol 2009, 28:103-108. 10.1089/dna.2008.0792, 2925039, 19182996.
    • (2009) DNA Cell Biol , vol.28 , pp. 103-108
    • Popov, S.1    Mirshahidi, S.2    Essono, S.3    Song, R.4    Wang, X.5    Ruprecht, R.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.